Tablet Health review
Tablet Health lists oral and injected GLP-1 products. Its oral tirzepatide offering should not be mistaken for an FDA-approved version of an injectable brand.
The verdict
Tablet makes product formats and introductory-versus-later pricing visible, but choosing an oral product requires a careful evidence discussion. Convenience does not establish that compounded oral tirzepatide behaves like the injections studied in major trials. Ask the clinician about formulation-specific evidence and approved alternatives.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Tablet Health offers online clinical access and prescription fulfillment for weight management, alongside other treatments. Its catalog includes semaglutide and tirzepatide in oral and injection categories. A product menu does not establish equal effectiveness across those formulations.
Who writes the prescription, and what do they see?
The terms require a provider to review health information, decide appropriateness and issue a valid prescription. Medical groups and dispensing pharmacies have separate responsibilities from the platform. Confirm the clinician and the pharmacy responsible for your particular product.
The site describes consultation after checkout, personalized dosing and continued check-ins. Before paying, ask how the consultation is conducted and what happens financially if the product is unsuitable. General support and same-day dispatch claims do not answer clinical follow-up questions.
What happens when the dose goes up?
Personalized dosing is advertised, but public format labels do not establish a safe conversion between oral and injected medicine. Discuss the actual formulation and planned dose with the clinician; do not substitute a product based on the ingredient name alone.
What the price includes
The oral tirzepatide page explicitly separates a first-month offer from a higher continuing monthly amount and longer packages. Product-specific renewal terms matter: the homepage’s starting figure is not a permanent rate for every formulation.
What it claims, and what it cites
The catalog includes compounded injections and oral GLP-1 preparations. There is no FDA-approved oral tirzepatide medicine; ingredient or laboratory claims do not approve a finished compounded tablet. Ask for the prescribed ingredients, concentration and dispensing instructions.
Where it holds up, and where it does not
- Strength: Different formats identified in the catalog
- Strength: A continuing oral-product price disclosed
- Strength: Provider approval required in the terms
- Limitation: Oral tirzepatide lacks an FDA-approved counterpart
- Limitation: Consultation follows checkout
- Limitation: Subscription cancellation has an advance deadline
What the evidence says about this kind of treatment
The assessment above is about Tablet Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A patient comparing formulations with a clinician and willing to examine product-specific evidence and terms.
- Wrong for
- Someone assuming every GLP-1 tablet is interchangeable with an approved injection.
The evidence behind what Tablet Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Tablet Health compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Teladoc HealthTeleios HealthTeleWellnessMDThe ProtocoleTideMedixTomorrow
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is oral tirzepatide FDA approved?
- No. The evidence and approvals for injectable tirzepatide do not approve a compounded oral preparation.
- Can I choose a pharmacy?
- The terms allow a requested pharmacy if it can fulfill the prescription, with separate payment arrangements potentially applying.
Sources for this review
Provider information checked . Terms can change.